TMO vs IDXX — Key Metrics
| Metric | TMO (THERMO FISHER SCIENTIFIC INC) | IDXX (IDEXX LABORATORIES INC) |
|---|---|---|
| Price | 692.74 | 698.47 |
| Market Cap | 256.67 Billion | 55.03 Billion |
| P/E (TTM) | 36.48 | 46.81 |
| P/B (Quarterly) | 4.716 | 28.31 |
| P/S (TTM) | 5.42 | 11.8 |
| Net Profit Margin (TTM) | 14.9 | 25.4 |
| Gross Margin (TTM) | 41.1 | 62.7 |
| ROE (TTM) | 13.3 | 71.2 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Greatly Underperform
Recommendation Summary
Both stocks are projected to greatly underperform the market over the next year. If you have to make a choice, Upfront Recommendation: TMO.
Financial Metrics
| TMO | Metrics | IDXX |
|---|---|---|
| $692.74 | Price | $698.47 |
| — | Market Capitalization | — |
| 36.48 | Price to Earnings Ratio | 46.81 |
| 5.42 | Price to Sales | 11.8 |
| 33.61 | Price to FCF Ratio | 42.65 |
| 13.19 | Price to Gross Profit | 18.82 |
| 182.81 | Price to R&D | 206.21 |
| 10.02 | Price to Current Assets | 36.69 |
TMO vs IDXX at a glance
Thermo Fisher Scientific INC (TMO) and Idexx Laboratories INC (IDXX) are both Diagnostics & Research companies in the Healthcare sector. TMO is the larger, at $256.7 billion in market value against $55.0 billion for IDXX, about 4.7 times the size.
On trailing-twelve-month figures, TMO trades at 36.5 times trailing earnings and IDXX at 46.8; net profit margins are 14.9% and 25.4%.
The Upfront Investment model currently rates both Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.